Home
Home
About NYBA
About NYBA
Mission Statement
Board of Directors
Publication
Publication
Annual Reports
Speeches,Letters, Presentations
Annual Meeting Archive
NYBA Survey
Purchasing Consortium
Member Directory
Public Policy
Public Policy
NYBA Action
Industry Issues & Initiatives
Calendar
Calendar
Submit Event
NYBA Annual Meeting
Registration
Meeting Sponsor's Page
Sponsorships and Advertising Opportunities
Press Room
Press Release
Press Release
Press Release Archive
NYBA in the News
Member News
Member News
Stories pages
Life Sciences News(Businesswire)
Newsletter
Newsletter
Newsletter Archive
New York Biotech Center
New York Biotech Center
New York's Biotech Strengths
New York Biotech Initiatives
New York Biotech Initiatives
NYSTAR
Research & Development Where in New York
Research & Development Where in New York
Tech Transfer Directory
Academic Facilities
Incubators & Tech Parks
Sources of Funding
Government Economic Development Offices
Patent Advocacy Groups
NYBA Biotechnology Genealogy Database
NYBA's New York BioWeb
NYBA's New York BioWeb
Submit Link Form
Join NYBA
Join NYBA
Benefits of Membership
Application
Purchasing Consortium
Sponsorships and Advertising Opportunities
Member Directory
Careers
Search Openings
Search Resumes
Submit Resume
Submit Job
Job Profiles
Member Directory
Notices
Contact Us
Site Map
New York Biotechnology Association Announces Search For New Executive Director
The New York Biotechnology Association (NYBA), a not-for-profit trade...
06/ 29/ 2007
More…
New York Biotechnology Headlines
Today is September 06, 2008. All times in Eastern Daylight Time.
09/05/2008 - 09:16 AM
A New Potential Path to Curing Inflammatory Bowel Diseases Emerges through Gene Research Funded by the Crohn's & Colitis Foundation of America
09/04/2008 - 04:15 PM
InSite Vision Announces Webcast of Presentation at The Wall Street Analyst Forum's 19th Annual Institutional Investor Conference
09/04/2008 - 10:22 AM
Healthnostics Meets Significant Milestones
09/04/2008 - 10:00 AM
The Discovery Stage Partnering Agreements in Biopharma Report Provides Data on Deal Trends Since 2000, Over 1000 Actual Contracts and Real Case Studies
09/04/2008 - 09:30 AM
ABMC Products to Be Used by the French Ministry of Interior
09/04/2008 - 09:07 AM
Q Pharma, Inc. Names Bryan Koslow Vice President of Sales and Marketing
09/04/2008 - 09:05 AM
NovaDel Announces Data from Pilot Efficacy Study Comparing Sumatriptan Oral Spray to Imitrex(R) Tablets
09/04/2008 - 08:00 AM
Bio-Imaging Technologies to Present at Baird's 2008 Small Cap Health Care Conference September 10, 2008
09/04/2008 - 06:00 AM
Anadis Commercializing "BioGard" Adjunctive Therapy for HIV & AIDS
09/03/2008 - 04:30 PM
Biodel to Report Results of VIAject(TM) Pivotal Phase III Clinical Trials at EASD Conference
09/03/2008 - 04:30 PM
Celgene Corporation to Present at the 3rd Annual Citi Biotech Day
09/03/2008 - 04:30 PM
AMRI Announces Leadership Changes in Pharmaceutical Development and Manufacturing
09/03/2008 - 04:00 PM
Biovail Announces Filing of ANDA for Fenofibrate Tablets
09/03/2008 - 02:00 PM
Teva and Barr Receive FTC Request for Additional Information
09/03/2008 - 12:00 PM
ImClone Submits Supplemental Biologics License Application for ERBITUX(R) in First-Line Head and Neck Cancer
09/03/2008 - 12:00 PM
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality Following Angioplasty in Severe Heart Attack Patients
09/03/2008 - 11:43 AM
Research and Markets: Examine BSD Medical Corporation's Product Pipeline with New Analysis
09/03/2008 - 11:04 AM
Wall Street Analyst Forum 2008 Presenter Profiles for AVANIR Pharmaceuticals and DRI Corporation
09/03/2008 - 11:04 AM
Heartbeat Digital Recognized as Google Adwords-Qualified Agency
09/03/2008 - 09:37 AM
Redpoint Bio to Present at the 19th Annual Wall Street Analyst Conference
09/03/2008 - 09:15 AM
Bristol-Myers Squibb and AstraZeneca to Hold Investor Teleconference to Discuss EASD Highlights
09/03/2008 - 08:01 AM
Neurologix Licenses Exclusive Rights to Key Gene from Aegera Therapeutics for Use as a Potential Gene Therapy for Huntington's Disease
09/03/2008 - 08:00 AM
Pall Corporation Acquires Molecular Diagnostics Manufacturer GeneSystems
09/03/2008 - 07:30 AM
OSI Pharmaceuticals Initiates Clinical Development Program for Anti-Diabetes Candidate, PSN821
09/03/2008 - 07:30 AM
Celgene Corporation to Present at the Thomas Weisel Partners Experts in Growth Healthcare Conference 2008
1
2
NEXT »
Terms of Use
|
©2008 Business Wire
© 2007 New York Biotechnology Association
HOME
|
ABOUT NYBA
|
CONTACT US
|
NOTICES
|
SITE MAP
Website by Axxiem
